Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-26 | 225793 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-04-26 | 2024-04-26 | 226309 |
APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226312 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2024-04-26 | 2024-04-26 | 226318 |
APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226321 |
APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226324 |
APO-MIRTAZAPINE | 45MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226333 |
APO-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226336 |
APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226342 |
APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226345 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-26 | 2024-04-26 | 226348 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2024-04-19 | 2024-05-03 | 225785 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-03 | 221705 |
APO-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-03 | 225773 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2024-03-15 | 2024-05-03 | 222481 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-12-22 | 2024-05-03 | 214247 |
APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223543 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-04-19 | 2024-05-03 | 225761 |
APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-03 | 226339 |
APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223546 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
APO-ENALAPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |